Literature DB >> 2649023

A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis.

B M Selwyn1, C D Figueroa, E Fink, A Swan, P A Dieppe, K D Bhoola.   

Abstract

Tissue kallikrein is an enzyme that forms the vasoactive peptide kallidin from an endogenous substrate L-kininogen. Tissue kallikrein has been identified in joint fluids and in inflammatory infiltrates within synovial membranes. It is suggested that tissue kallikrein and kinins have an important role in synovitis and joint damage. Immunoreactive tissue kallikrein and amidase activity were both measured in the synovial fluid of 24 patients with rheumatoid arthritis (RA) and 12 with osteoarthritis (OA). Active enzyme concentrations were higher in RA than in OA and correlated well with the lysosomal enzymes beta-glucuronidase and lactate dehydrogenase. Both total immunoreactive tissue kallikrein and the proenzyme values were similar in RA and OA. Tissue kallikrein was localised by immunocytochemistry to the polymorphonuclear leucocytes present in the synovial fluid and membranes of patients with RA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649023      PMCID: PMC1003698          DOI: 10.1136/ard.48.2.128

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Proteinase inhibitors in rheumatoid arthritis.

Authors:  D Brackertz; J Hagmann; F Kueppers
Journal:  Ann Rheum Dis       Date:  1975-06       Impact factor: 19.103

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 3.  Kallikreins (kininogenases)--a group of serine proteases with bioregulatory actions.

Authors:  M Schachter
Journal:  Pharmacol Rev       Date:  1979-03       Impact factor: 25.468

4.  Inhibition of erythrocyte pseudoperoxidase activity by treatment with hydrogen peroxide following methanol.

Authors:  J G Streefkerk
Journal:  J Histochem Cytochem       Date:  1972-10       Impact factor: 2.479

5.  Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases. Origin and relation to disease category.

Authors:  M K Jasani; M Katori; G P Lewis
Journal:  Ann Rheum Dis       Date:  1969-09       Impact factor: 19.103

6.  Plasma kinins in synovial exudates.

Authors:  V Eisen
Journal:  Br J Exp Pathol       Date:  1970-06

7.  Urates and kinin formation in synovial fluid.

Authors:  V Eisen
Journal:  Proc R Soc Med       Date:  1966-04

8.  Kallikrein inhibitors in rat plasma.

Authors:  Y Hojima; M Isobe; H Moriya
Journal:  J Biochem       Date:  1977-01       Impact factor: 3.387

9.  Antitrypsin activity and enzyme inhibitors in the rheumatoid joint.

Authors:  A D Robinson; K N Boyden; S M Hendrickson; K D Muirden
Journal:  J Rheumatol       Date:  1981 Jul-Aug       Impact factor: 4.666

10.  Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study.

Authors:  G MAJNO; G E PALADE
Journal:  J Biophys Biochem Cytol       Date:  1961-12
View more
  8 in total

Review 1.  Kallikreins and kinins: mediators in inflammatory joint disease?

Authors:  K Worthy; C D Figueroa; P A Dieppe; K D Bhoola
Journal:  Int J Exp Pathol       Date:  1990-08       Impact factor: 1.925

2.  Augmented plasma and tissue kallikrein like activity in synovial fluid of patients with inflammatory articular diseases.

Authors:  N Volpe-Júnior; E A Donadi; I F Carvalho; M L Reis
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

3.  Identification of tissue kallikrein messenger RNA in human neutrophils.

Authors:  H F Wu; R D Venezie; W M Cohen; J W Jenzano; G L Featherstone; R L Lundblad
Journal:  Agents Actions       Date:  1993-01

4.  Evidence for activation of the tissue kallikrein-kinin system in nociceptive transmission and inflammatory responses of mice using a specific enzyme inhibitor.

Authors:  J A da S Emim; C Souccar; M S de A Castro; R O Godinho; M H Cezari; L Juliano; A J Lapa
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  N-methyl pyrrolidone promotes ankle fracture healing by inhibiting inflammation via suppression of the mitogen-activated protein kinase signaling pathway.

Authors:  Jun Bian; Dan Cao; Jie Shen; Bo Jiang; Dan Chen; Lanzheng Bian
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

6.  Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides.

Authors:  J M Bathon; D Proud; S Mizutani; P E Ward
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies.

Authors:  K Wirth; F J Hock; U Albus; W Linz; H G Alpermann; H Anagnostopoulos; S Henk; G Breipohl; W König; J Knolle
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

8.  An Extensive Study of the Functional Polymorphisms of Kinin-Kallikrein System in Rheumatoid Arthritis Susceptibility.

Authors:  Anthoula Chatzikyriakidou; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Arch Rheumatol       Date:  2017-09-13       Impact factor: 1.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.